S
Steven R. Pliszka
Researcher at University of Texas Health Science Center at San Antonio
Publications - 112
Citations - 11242
Steven R. Pliszka is an academic researcher from University of Texas Health Science Center at San Antonio. The author has contributed to research in topics: Attention deficit hyperactivity disorder & Bipolar disorder. The author has an hindex of 54, co-authored 110 publications receiving 10712 citations. Previous affiliations of Steven R. Pliszka include University of Texas at Austin & University of Texas Health Science Center at Houston.
Papers
More filters
Journal ArticleDOI
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
Steven R. Pliszka,William Bernet,Oscar G. Bukstein,Heather J. Walter,Valerie Arnold,Joseph H. Beitchman,R. Scott Benson,Allan K. Chrisman,John D. Hamilton,Helene Keable,Joan Kinlan,Jon McClellan,David Rue,Ulrich Schoettle,Saundra Stock,Kristin Kroeger Ptakowski,Jennifer Medicus,Larry Greenhill,Timothy E. Wilens,Thomas J. Spencer,Joe Biederman,Mina K. Dulcan,Lily Hechtman,Caryn L. Carlson,William E. Pelham,James M. Swanson,Russell A. Barkley,Joan P. Gerring,Guy Palmes,Cynthia W. Santos,Catherine Jaselskis +30 more
TL;DR: This practice parameter describes the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder (ADHD) based on the current scientific evidence and clinical consensus of experts in the field.
Journal ArticleDOI
Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults
TL;DR: This practice parameter describes treatment with stimulant medication, which carries FDA indications for treatment of attention-deficit/hyperactivity disorder and narcolepsy.
Journal ArticleDOI
Attention-deficit-hyperactivity disorder: an update.
TL;DR: This patient population can be treated effectively with individualized treatment regimens of stimulants, atomoxetine, or bupropion, along with close monitoring, and longacting formulations (administered once/day) may improve adherence.
Journal ArticleDOI
Catecholamines in attention-deficit hyperactivity disorder: Current perspectives
TL;DR: A multistage hypothesis is presented which emphasizes the interaction of norepinephrine, epinephrine, and dopamine in modulation of attention and impulse control.
Journal ArticleDOI
The texas children's medication algorithm project : Revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder
Steven R. Pliszka,Steven R. Pliszka,Steven R. Pliszka,M. Lynn Crismon,Carroll W. Hughes,C. Keith Corners,Graham J. Emslie,Graham J. Emslie,Peter S. Jensen,James T. McCracken,James M. Swanson,Molly A Lopez +11 more
TL;DR: Medication algorithms for ADHD can be modified to keep abreast of developments in the field and may be a useful approach to guide the treatment of ADHD in children.